ACSM3
Acyl-CoA synthetase medium-chain family member 3 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||
Symbols | ACSM3 ; SA; SAH | ||||||||||
External IDs | Template:OMIM5 Template:MGI HomoloGene: 74559 | ||||||||||
| |||||||||||
RNA expression pattern | |||||||||||
More reference expression data | |||||||||||
Orthologs | |||||||||||
Template:GNF Ortholog box | |||||||||||
Species | Human | Mouse | |||||||||
Entrez | n/a | n/a | |||||||||
Ensembl | n/a | n/a | |||||||||
UniProt | n/a | n/a | |||||||||
RefSeq (mRNA) | n/a | n/a | |||||||||
RefSeq (protein) | n/a | n/a | |||||||||
Location (UCSC) | n/a | n/a | |||||||||
PubMed search | n/a | n/a |
Acyl-CoA synthetase medium-chain family member 3, also known as ACSM3, is a human gene.[1]
References
Further reading
- Nabika T, Bonnardeaux A, James M; et al. (1995). "Evaluation of the SA locus in human hypertension". Hypertension. 25 (1): 6–13. PMID 7843754.
- Iwai N, Ohmichi N, Hanai K; et al. (1994). "Human SA gene locus as a candidate locus for essential hypertension". Hypertension. 23 (3): 375–80. PMID 7907320.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
- Samani NJ, Whitmore SA, Kaiser MA; et al. (1994). "Chromosomal assignment of the human SA gene to 16p13.11 and demonstration of its expression in the kidney". Biochem. Biophys. Res. Commun. 199 (2): 862–8. doi:10.1006/bbrc.1994.1308. PMID 8135833.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
- Loftus BJ, Kim UJ, Sneddon VP; et al. (1999). "Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q". Genomics. 60 (3): 295–308. doi:10.1006/geno.1999.5927. PMID 10493829.
- Fujino T, Takei YA, Sone H; et al. (2001). "Molecular identification and characterization of two medium-chain acyl-CoA synthetases, MACS1 and the Sa gene product". J. Biol. Chem. 276 (38): 35961–6. doi:10.1074/jbc.M106651200. PMID 11470804.
- Iwai N, Katsuya T, Mannami T; et al. (2002). "Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension". Circulation. 105 (1): 41–7. PMID 11772874.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Narita I, Saito N, Goto S; et al. (2003). "Role of genetic polymorphism in the SA gene on the blood pressure and prognosis of renal function in patients with immunoglobulin A nephropathy". Hypertens. Res. 25 (6): 831–6. PMID 12484505.
- Benjafield AV, Iwai N, Ishikawa K; et al. (2004). "Overweight, but not hypertension, is associated with SAH polymorphisms in Caucasians with essential hypertension". Hypertens. Res. 26 (8): 591–5. PMID 14567496.
- Telgmann R, Brand E, Nicaud V; et al. (2007). "SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study". J. Hypertens. 25 (3): 557–64. doi:10.1097/HJH.0b013e3280144779. PMID 17278971.
This protein-related article is a stub. You can help Wikipedia by expanding it. |